Litcius/Paper detail

Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial

Lorenz Leitner, Aleksandre Ujmajuridze, Ніна Чанішвілі, Marina Goderdzishvili, Irina Chkonia, Sophio Rigvava, Archil Chkhotua, Giorgi Changashvili, Shawna McCallin, Marc P. Schneider, Martina D. Liechti, Ulrich Mehnert, Lucas M. Bachmann, Wilbert Sybesma, Thomas M. Kessler

2020The Lancet Infectious Diseases312 citationsDOI

Topics & Concepts

MedicineUrinary systemTransurethral resection of the prostatePlaceboDouble blindProstateUrologyRandomized controlled trialClinical trialResectionLower urinary tract symptomsSurgeryInternal medicineCancerPathologyAlternative medicineUrinary Tract Infections ManagementBladder and Urothelial Cancer TreatmentsReproductive tract infections research
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial | Litcius